Carl W Rausch

This inventor holds 14 USPTO granted patents and 3 published patent applications, primarily in Hemoglobin Solutions. Top assignees: Biopure Corporation, Dana-Farber-Cancer Institute Inc., Biopure Corportion. Active years: 1992-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl W Rausch. Retrieved from https://idiyas.com/inventor/carl-w-rausch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 9

Forward Citations = 281(Granted Patents)

Location History:

Providence, RI (US) (1992 - 2003)
Medford, MA (US) (1994 - 2003)

Company Filing History:

Dana-Farber-Cancer Institute Inc.

where one patent can have more than one assignee

Years Active: 1992-2003

Loading Chart...

Areas of Expertise:

Hemoglobin

Blood Substitutes

Tumor Treatment

Oxygenation

Polymerized Hemoglobin

Chemotherapeutic Agents

Red Blood Cell Flow

Ultra Pure Solutions

Purification Methods

Stable Products

Semi-Synthetic Blood

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6541449 - Increasing function of organs having reduced red blood cell flow (2003-04-01),

2. 6506725 - Ultra pure hemoglobin solutions and blood-substitutes (2003-01-14),

3. 6150507 - Method for producing a purified hemoglobin product (2000-11-21),

4. 5955581 - Method for producing a stable polymerized hemoglobin blood-substitute (1999-09-21),

5. 5905141 - Ultra pure hemoglobin solutions and blood substitutes (1999-05-18),

6. 5854209 - Method for oxygenating tissue having reduced red blood cell flow (1998-12-29),

7. 5840852 - Method for producing ultrapure stable polmerized hemoglobin (1998-11-24),

8. 5776898 - Method for treating a tumor with a chemotherapeutic agent (1998-07-07),

9. 5753616 - Method for producing a stable polymerized hemoglobin blood-substitute (1998-05-19),

10. 5679638 - Method for treating a tumor with a chemotherapeutic agent (1997-10-21),

11. 5618919 - Ultra pure hemoglobin solutions and blood-substitutes (1997-04-08),

12. 5296465 - Ultra pure hemoglobin solutions and blood-substitutes (1994-03-22),

13. 5295944 - Method for treating a tumor with ionizing radiation (1994-03-22),

14. 5084558 - Extra pure semi-synthetic blood substitute (1992-01-28),

Title: The Innovations of Carl W Rausch

Introduction

Carl W Rausch is a notable inventor based in Medford, MA (US), recognized for his significant contributions to the field of medical technology. With a total of 14 patents to his name, Rausch has focused on enhancing tissue oxygenation and developing blood substitutes.

Latest Patents

Among his latest patents, Rausch has developed a method for increasing the function of organs that experience reduced red blood cell flow. This invention aims to therapeutically treat vertebrates by introducing hemoglobin into their circulatory systems to improve tissue oxygenation. Another significant patent involves the creation of ultra-pure hemoglobin solutions and blood substitutes. This process includes fractionating whole blood and cross-linking a sterile hemoglobin solution to ensure it is free from endotoxins.

Career Highlights

Throughout his career, Rausch has worked with prominent organizations such as Biopure Corporation and Dana-Farber Cancer Institute Inc. His work has been instrumental in advancing medical treatments and technologies.

Collaborations

Rausch has collaborated with notable colleagues, including Mario J Feola and Robert A Houtchens, contributing to the development of innovative medical solutions.

Conclusion

Carl W Rausch's contributions to medical technology through his patents and collaborations have made a significant impact in the field. His work continues to influence advancements in therapeutic treatments and blood substitutes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents pending: